programme specifications bachelor of pharmaceutical sciences · programme specifications bachelor...

Faculty of Pharmacy Programme Specifications Cairo University 2010

F-730-01-03

1

Programme Specifications

Bachelor of Pharmaceutical Sciences

(2010)

A- Administrative Information

1. Programme title: Bachelor Degree in Pharmaceutical Sciences

2. Programme type: Single

3. Award / degree: Bachelor Degree in Pharmaceutical Sciences

4. Department responsible:

a. Department of Pharmaceutics.

b. Department of Pharmacognosy.

c. Department of Pharmacology and Toxicology.

d. Department of Microbiology and Immunology.

e. Department of Organic Chemistry.

f. Department of Analytical Chemistry.

g. Department of Biochemistry.

h. Department of Pharmaceutical Chemistry.

i. Department of Clinical Pharmacy.

5. Coordinator: Prof. Dr. Seham Elkheshen, Vice-Dean for Educational and Students Affairs

6. External evaluator: - Prof. Dr. Soad Mohamed Abdel-Khalik,Professor of Pharmacognosy,

Faculty of Pharmacy, Helwan University

- Prof. Dr. Saeed Al-Feki, Professor of Organic Chemistry, Faculty of

Pharmacy,Zagazig University

7. Date of the most recent approval of programme specifications by the faculty

council:26/10/2010

B- Professional Information

1. Programme aims:

The main aim of the undergraduate programme is to foster pharmacists who can attain a

successful career and provide skilled and ethical pharmaceutical care. This is achieved

through developing a programme with an appropriate mix of basic, pharmaceutical, medical,

social, behavioral management, health and environmental sciences. The multidisciplinary

courses of our programme prepare our pharmacy graduates to work in any of the various

fields of pharmacy including community pharmacies, hospitals, pharmaceutical firms,

pharmaceutical Industrial companies as well as, academic and research institutes.

I. Attributes of the graduates:

The graduates of the Faculty of Pharmacy, Cairo University should demonstrate

outstanding skills as follows:

I.1. Be able to deal with and handle chemicals and natural products in a safe way.

I.2. Handle pharmaceutical products effectively according to pharmacy law and

legislations.


F-730-01-03

2

I.3. Use materials from different sources in preparation and formulation of different

products.

I.4. Formulate and dispense different pharmaceutical products.

I.5. Store and distribute drug products according to good storage practice

I.6. Apply principles of quality control and quality assurancefor pharmaceutical products

and natural products.

I.7. Analyze qualitatively and quantitatively raw materials, pharmaceutical products, and

biological samples

I.8. Perform according to Good Laboratory Practice (GLP), Good Pharmaceutical

Manufacturing Practice (GPMP)and current Good Manufacturing Practice (cGMP)

guidelines

I.9. Educate patients and community about proper and safe use of medications as well as

risks of abuse drugs, radiation and different xenobiotics.

I.10. Provide patients with information about the purpose and use of medications and

medical devicesas well as management of toxicities and medical emergencies.

I.11. Demonstrate principles of understanding of etiology, pathophysiology and

management of diseases.

I.12. Work effectively with different health care professionals using evidence based

information.

I.13. Plan, design and conduct research

I.14. Demonstrate good presentation, marketing and business administration skills

I.15. Develop numeracy and statistics skills

I.16. Develop information technology skills

I.17. Communicate clearly with different professions

I.18. Demonstrate problem solving and time management skills.

I.19. Demonstrate capability of decision-making and working in a team.

I.20. Apply legal, ethical, social, cultural, economical and professional codes.

I.21. Implement different professional skills throughout his professional career.

I.22. Upgrade his/her professional and scientific information by continuouslearning.


F-730-01-03

3

2. Intended learning outcomes (ILOs) for programme

II. Knowledge and understanding:

The pharmacy graduate must demonstrate comprehensive knowledge and clear

understanding of the core information associated with the profession as follows:

II.1. Basic principles of physical, organic, inorganic and analytical chemistry.

II.2. Basic principles of mathematics, computer sciences, and biophysics.

II.3. Principles of pharmaceutical, medical, health and environmental sciences as well as

pharmacy practice.

II.4. Principles of social, behavioural and pharmacy management sciences.

II.5. Types of active and inactive ingredients used in the preparation of pharmaceutical

products as well as their physical and chemical properties.

II.6. Principles of biotechnology and radio-labelled products.

II.7. Different analytical procedures taking into account GLP guidelines and different

validation procedures

II.8. Principles of isolation, purification, identification and standardization methods of

active substances and primary chemicals from natural and synthetic origin.

II.9. Principles of synthesis and purification of active pharmaceutical ingredients

II.10. Basics of stereoisomerism, drug-receptor interaction using various techniques.

II.11. Pharmacodynamics of existing drugs to develop and synthesize new drugs.

II.12. Fundamentals of clinical applications of targeted therapies

II.13. Different types of pharmaceutical dosage forms.

II.14. Properties and advantages of novel drug delivery systems

II.15. Principles of equipment and techniques used in different stages of pharmaceutical

industry including synthesis, and distribution of pharmaceutical compounds.

II.16. Unit operation and unit processes; sampling, packaging, labelling and proper storage

of pharmaceutical compoundsfrom different origins.

II.17. Basics of pharmacokinetics and biopharmaceutics principles.

II.18. Therapeutic drug monitoring, dose adjustmentand bioequivalence studies.

II.19. Principles ofhospital pharmacy including total parentral nutrition and drug distribution

system.


F-730-01-03

4

II.20. Sources and control of microbial contaminations, sanitation, disinfection, and other

public health issues.

II.21. Principles of sterilization and microbiological quality control of pharmaceutical

products.

II.22. Principles of physiology and pathophysiology.

II.23. Principles of genomics and molecular biology technique.

II.24. Biochemical pathways and their correlation with various diseases.

II.25. Etiology, signs and symptoms of different diseases.

II.26. Interpretation of different laboratory diagnostic results.

II.27. Mechanism of action, therapeutic use, dosage of different pharmacological drug

classesas well as, from natural origin.

II.28. Adverse drug reactions, interactions, contraindications and other properties of

different pharmacological drug classesincluding drugs of natural sources.

II.29. Basis of clinical pharmacology, and rationaldrug use.

II.30. Principles of alternative and complementary therapy.

II.31. Toxicological characteristics of xenobiotics including origin and identification.

II.32. Toxicity symptoms and control measures.

II.33. Principles of first aid measures.

II.34. Basics ofmathematics,biostatistical analysis and pharmaceutical calculations.

II.35. Principles of accounting and pharmacoeconomics.

II.36. Principles of pharmaceutical business administration and management.

II.37. Basis of drug sales, marketing and drug promotion.

II.38. Basics of drug documentation and drug approval process.

II.39. Pharmacy laws and ethics as well as governmental regulations.


F-730-01-03

5

III. Professional and practical skills

By successful completion of the programme, students should have the following skills:

III.1. Proper use ofinternational union of pure and applied chemistry (IUPAC)

nomenclature as well as pharmaceutical and medical terminology.

III.2. Handle chemicals and natural products according to safety guidelines.

III.3. Dispose hazardous solvents in laboratories using safety measures.

III.4. Demonstrate skills in compounding and dispensing pharmaceutical preparations

III.5. Apply adequate conditions for storing, handling and distribution of pharmaceutical

preparations according to their nature and constitution as stated in the specified

storage conditions.

III.6. Extract and isolate active ingredients from different sources.

III.7. Synthesize preliminary chemical substances and active constituents of different drug

categories.

III.8. Purify and identify the newly synthesized chemical compounds or drugs.

III.9. Detect impurities in different pharmaceutical preparations and assess their limits.

III.10. Estimate different active ingredients using various analytical tools and techniques.

III.11. Select the appropriate medication therapy for a given disease based on its etiology,

pathophysiology, severity,patient medical history, possible interactions and age-

related factors.

III.12. Evaluate the selected drug therapy based on the patient`s progress and laboratory

results.

III.13. Perform the suitable laboratory tests to diagnose infectious and non-infectious

diseases.

III.14. Apply the appropriate techniques for qualitative and quantitative assessment of

microbial growth.

III.15. Assess the activity of different antimicrobial agents in controlling microbial growth.

III.16. Investigate toxicity profiles of different xenobiotics

III.17. Test for poisons in biological samples.

III.18. Determine drug metabolites in biological samples.


F-730-01-03

6

III.19. Operate and maintain laboratory and manufacturing equipments and instruments

safely and efficiently.

III.20. Maintain public awareness on social health hazards of drug abuse and misuse.

III.21. Counsel the patients and other health care professions about the proper and safe use

of medicinesfrom different sources and possible interactions with other drugs or

food.

III.22. Educate patients about the appropriate health measures they should maintain during

and after drug administration.

III.23. Advise health care professionals about safety and efficacy of pharmaceutical

products.

III.24. Perform research studies based on scientific background and rationale approach with

good interpretation and analysis of the obtained results.

III.25. Demonstrate ability in preparing drug reports.

III.26. Adopt suitable documentation

IV. Intellectual skills

By successful completion of the programme, students should show the following skills:

IV.1. Use pharmaceutical knowledge in formulating safe and effective medicines.

IV.2. Deal properly with new drug delivery systems.

IV.3. Implement GLP, GMP, GSP, GCP and GPMP guidelines in pharmacy practice.

IV.4. Select appropriate tools or analytical method for the assay and quality control of raw

materials and pharmaceutical products.

IV.5. Select appropriate biological method for the assay of different drug classes.

IV.6. Predict and prevent physical, chemical and biological incompatibilities during

dispensing process.

IV.7. Select suitable methods for isolation, identification and standardization of active

pharmaceutical substances.

IV.8. Select suitable methods for synthesis, purification and identification of active

pharmaceutical substances.

IV.9. Apply mathematics, computer-aided facilities, biological databases and bio-

informatics in drug design.


F-730-01-03

7

IV.10. Apply molecular modelling techniques in drug design.

IV.11. Utilize different tools to estimate the properties of biopharmaceuticalsnatural

pharmaceutical products.

IV.12. Select different methods for infection control and improve public health.

IV.13. Apply pharmacological and pharmacotherapeutic principles in the proper selection of

drugs from different sources for the management of different diseases.

IV.14. Adjust the dose of different medication based on patient condition and select

appropriate dose regimen.

IV.15. Identify adverse drug reactions, interactions and contra-indications of different

pharmaceutical drug classes.

IV.16. Apply the pharmacoeconomics principles in maintaining drug effectiveness with

reducing the drug.

IV.17. Interpret and report on results obtained from experimental studies.

IV.18. Evaluate data from published literature using critical analysis.

IV.19. Apply evidence-based guidelines, involving sciences, technology, psychology and

professional principles required in pharmacy practice.

V. General and transferable skills

By successful completion of the programme, students should have the following skills:

V.1. Communicate clearly by verbal means.

V.2. Write report on the interpreted results of his/her research projects.

V.3. Search the literature from different sources including the library, internet ….etc.

V.4. Evaluate the information obtained from different sources.

V.5. Share and participate effectively in team work.

V.6. Calculate and statistically analyze data.

V.7. Demonstrate good information technology skills.

V.8. Demonstrate self-learning skills.

V.9. Be coherent with pharmaceutical ethical, legal and safety guidelines.

V.10. Implement different skills required for sales, marketing and pharmacy

administration.


F-730-01-03

8

V.11. Work effectively in a creative way within pre-determined time frame.

V.12. Develop different writing and presentation skills.

V.13. Evaluate and make decision to deal with different problems.

3. Academic standards

3.a. External references selected to confirm the appropriateness of academic standards

NARS was adopted as external reference guiding the Faculty of Pharmacy – Cairo

University to create its own academic standards.

3.b. Comparison of provision to selected external references.

The academic standards and educational programme committee (ASEPC) of Faculty of

Pharmacy, Cairo University has performed a comparative study of NARS vs. its

programme ILOs which was approved by both external and internal evaluators (Table 1).


F-730-01-03

9

Ta

ble

(1

): C

om

pa

riso

n b

etw

ee

n N

AR

S &

P

ro

gra

mm

e IL

Os M

atrix

Pro

gra

mm

e IL

Os

Att

rib

ute

s of

the

Gra

du

ate

s

I.2

2

X

I.2

1

X

I.2

0

X

I.1

9

X

I.1

8

X

I.1

7

X

I.1

6

X

I.1

5

X

I.1

4

X

I.1

3

X

I.1

2

X

I.1

1

X

I.1

0

X

I.9

X

I.8

X

I.7

X

I.6

X

I.5

X

I.4

X

I.3

X

I.2

X

I.1

X

NA

RS

1.1

1.2

1.3

1.4

1.5

1.6

1.7

1.8

1.9

1.1

0


F-730-01-03

10

Pro

gra

mm

e IL

Os

Kn

ow

led

ge

an

d U

nd

erst

an

din

g

II.2

1

X

II.3

9

X

II.2

0

X

II.3

8

X

II.1

9

X

II.3

7

X

X

II.1

8

X

II.3

6

X

X

I.17

X

II.3

5

X

II.1

6

X

II.3

4

X

I.15

X

II.3

3

X

II.1

4

X

II.3

2

X

II.1

3

X

II.3

1

X

II.1

2

X

II.3

0

X

II.1

1

X

II.2

9

X

II.1

0

X

II.2

8

X

II.9

X

II.2

7

X

II.8

X

II.2

6

X

II.7

X

II.2

5

X

II.6

X

II.2

4

X

II.5

X

II.4

X

II.2

3

X

II.3

X

II.2

X

II.2

2

X

II.1

X

NA

RS

2.1

2.2

2.3

2.4

2.5

2.6

2.7

2.8

2.9

2.1

0

NA

RS

2.1

1

2.1

2

2.1

3

2.1

4

2.1

5

2.1

6

2.1

7

2.1

8

2.1

9

2.2

0

2.2

1


F-730-01-03

11

Pro

gra

mm

e IL

Os

Pro

fess

ion

al

& P

ract

ical

skil

ls

III.

26

X

III.

25

X

III.

24

X

III.

23

X

III.

22

X

III.

21

X

III.

20

X

III.

19

X

III.

18

X

III.

17

X

III.

16

X

III.

15

X

III.

14

X

III.

13

X

III.

12

X

III.

11

X

III.

10

X

III. 9 X

III. 8 X

III. 7 X

III. 6 X

III. 5 X

III. 4 X

III. 3 X

III. 2 X

III. 1

X

NARS 3.1

3.2

3.3

3.4

3.5

3.6

3.7

3.8

3.9

3.1

0

3.1

1

3.1

2


F-730-01-03

12

Pro

gra

mm

e IL

Os

Inte

llec

tual

skil

ls

IV.

19 X

IV.

18 X

IV.

17 X

IV.

16 X

IV.

15 X

IV.

14 X

IV.

13 X

IV.

12 X

IV.

11 X

IV.

10 X

IV.

9 X

IV.

8 X

IV.

7 X

IV.

6 X

IV.

5 X

IV.

4 X

IV.

3 X

IV.

2

X

IV .1

X

NA

RS

4.1

4.2

4.3

4.4

4.5

4.6

4.7

4.8

4.9

4.1

0

4.1

1

4.1

2

4.1

3

4.1

4


F-730-01-03

13

P

rogra

mm

e IL

Os

Gen

eral

an

d T

ran

sfer

ab

le S

kil

ls

V.1

3

X

V.1

2

X

V.1

1

X

V.1

0

X

V.9

X

V.8

X

V.7

X

V.6

X

V.5

X

V.4

X

V.3

X

V.2

X

V.1

X

NA

RS

5.1

5.2

5.3

5.4

5.5

5.6

5.7

5.8

5.9

5.1

0


F-730-01-03

14

Pro

gra

mm

e – C

ou

rse

IL

Os M

atrix

Pro

gra

mm

e IL

Os

Att

rib

ute

s of

the

Gra

du

ate

s

I.2

2

√

√

√ √

√

√ √

√

√ √ √

√ √

√

√ √

√

I.2

1

√

√

√ √ √ √ √

√

√

√ √

√

√ √

√

I.2

0

√ √ √ √ √ √ √ √

I.1

9

√

√ √

√

√ √

√ √ √

√

√ √ √

√

√ √

√

I.1

8

√

√

√

√

√

√

√

√

√ √ √

√ √ √

√ √

√ √

√

√ √

√

I.1

7

√

√ √

√

√

√ √

√

√ √

√

√

√ √

√

√ √

√

I.1

6

√ √

√ √ √ √ √

I.1

5

√

√ √

I.1

4

√ √

√ √ √ √

√

√ √ √ √

I.1

3

√ √ √ √ √ √

√ √

√

I.1

2

√ √ √

√ √

√ √

√

I.1

1

√ √ √ √ √

I.1

0

√ √ √ √

I.9

√ √

√ √

√

I.8

√ √ √ √

√ √

√ √

√ √ √

I.7

√ √

√ √

√

√ √

√

√

√ √

√

√ √ √ √

I.6

√ √ √ √

√

√ √

√

√ √

√

I.5

√ √ √

√ √

I.4

√ √ √

I.3

√ √ √ √ √

I.2

√ √ √ √

√ √

I.1

√ √

√

√ √ √

√

√

√ √ √

√ √ √

√ √

√

Co

urs

es

10

1

20

1

50

1

50

3

60

1

60

2

10

2

10

5

20

2

30

2

50

2

60

3

10

3

20

3

30

1

50

4

60

4

10

6

20

4

31

1

40

1

50

5

60

5

10

7

20

5

30

3

40

2

70

1

20

6

30

4


F-730-01-03

15

Pro

gra

mm

e IL

Os

Att

rib

ute

s of

the

Gra

du

ate

s

I.2

2

√

√ √

√

√

√

√ √ √

√

√ √ √

√ √

√

√

√

√

√

√

√

√

I.2

1

√ √

√

√

√

√

√

√

√ √

√

√

√ √

√

√ √

√

√

√

√

√ √

√

√

I.2

0

√ √

√ √

√

√

√ √

√

√

√ √ √ √

√ √

I.1

9

√

√

√

√ √

√

√

√ √

√

√

√ √

√

√ √

√ √

√

√ √

√

√

√

√

I.1

8

√

√

√

√

√ √

√

√

√

√

√

√

√

√ √

√

√ √

√ √

√

√

√

√

√

√

√

√

√

I.1

7

√ √

√

√ √ √

√

√ √

√ √ √

√ √

√

√

√

√

√

√ √

√

√

I.1

6

√ √ √ √ √ √ √

√

√ √ √

I.1

5

√ √ √

I.1

4

√

√ √ √ √ √

√ √ √

I.1

3

√ √ √

√

√ √ √ √

√ √

√ √

√

√

√

√

√

I.1

2

√ √

√

√ √ √ √

√ √ √ √

√

√ √

I.1

1

√

√ √ √ √

√ √ √

√ √

I.1

0

√ √

√ √

√ √

√

√ √

√

√ √ √ √

I.9

√ √

√

√

√ √ √

√ √ √ √ √ √ √

I.8

√ √

√ √

√

√ √ √

I.7

√ √

√ √

√ √

√

√

√ √

√

√

I.6

√ √

√

√

√ √

√

√

√ √

√

√

I.5

√ √

√

√

I.4

√ √

√

I.3

√ √

√

I.2

√ √ √ √ √ √

√ √

√

√

I.1

√

√ √

√ √ √ √ √ √

√

Co

urs

es

40

3

70

2

90

2

20

7

30

5

40

5

70

3

80

1

90

3

11

0

11

1

30

6

30

7

30

8

80

2

11

2

40

4

80

3

90

1

90

5

11

3

11

5

20

8

40

6

90

4

31

2

70

5

21

0

80

4

80

5

12

1

12

2

Su

mer

train

ing

ICD

L


F-730-01-03

16

Pro

gra

mm

e IL

Os

Kn

ow

led

ge

an

d U

nd

erst

an

din

g

II.2

1

II.3

9

√

II.2

0

II.3

8

√ √

√

II.1

9

II.3

7

√

√

II.1

8

I.36

√

I.17

II.3

5

√

II.1

6

√ √

II.3

4

√

√ √

II.1

5

√ √

II.3

3

√

II.1

4

√

II.3

2

II.1

3

√ √

II.3

1

II.1

2

II.3

0

√ √

II.1

1

II.2

9

II.1

0

√

II.2

8

√ √

II.9

II.2

7

√ √

II.8

√

√ √

√ √ √

II.2

6

√

II.7

√ √

√ √

II.2

5

√

√

II.6

√

II.2

4

√

II.5

√ √

√

√ √

II.4

√ √

√

√

II.2

3

√

II.3

√

√ √ √

√

II.2

√ √

√ √

II.2

2

√

II.1

√ √ √

√

√ √ √

Co

urs

es

10

1

20

1

50

1

50

3

60

1

60

2

10

2

10

5

20

2

30

2

50

2

Co

urs

es

10

1

20

1

50

1

50

3

60

1

60

2

10

2

10

5

20

2

30

2

50

2


F-730-01-03

17

Pro

gra

mm

e IL

Os

Kn

ow

led

ge

an

d U

nd

erst

an

din

g

II.2

1

II.3

9

II.2

0

√

II.3

8

II.1

9

√

II.3

7

II.1

8

I.36

I.17

II.3

5

II.1

6

II.3

4

√

√ √

II.1

5

√

II.3

3

II.1

4

√ √

II.3

2

√

II.1

3

√ √

II.3

1

√ √

II.1

2

√

II.3

0

√ √

II.1

1

II.2

9

√

√ √

II.1

0

√

II.2

8

√

II.9

√ √

II.2

7

√ √

II.8

√ √ √ √ √

II.2

6

√ √

II.7

√ √

√ √

II.2

5

√

II.6

√

II.2

4

√

II.5

√

√ √

√ √ √

II.4

√ √ √

II.2

3

II.3

√

√

√ √

√ √

II.2

√ √

II.2

2

√ √

II.1

√

√ √

√

√ √

Co

urs

es

60

3

10

3

20

3

30

1

50

4

60

4

10

6

20

4

31

1

40

1

50

5

Co

urs

es

60

3

10

3

20

3

30

1

50

4

60

4

10

6

20

4

31

1

40

1

50

5


F-730-01-03

18

Pro

gra

mm

e IL

Os

Kn

ow

led

ge

an

d U

nd

erst

an

din

g

II.2

1

√

II.3

9

II.2

0

√ √ √

II.3

8

√ √

√

II.1

9

√

II.3

7

II.1

8

√

I.36

I.17

√

II.3

5

II.1

6

II.3

4

√ √ √ √

II.1

5

II.3

3

II.1

4

√ √

II.3

2

√

II.1

3

√

II.3

1

√ √

II.1

2

√

√ √

√

II.3

0

√ √

II.1

1

√ √

II.2

9

√ √

II.1

0

√ √

II.2

8

√ √

√

II.9

√ √

II.2

7

√

√ √

II.8

√ √ √

√

II.2

6

√

√

√

II.7

√ √ √

√ √

II.2

5

√ √

√

√

II.6

II.2

4

√

√ √

√

√

II.5

√ √ √

II.4

√

II.2

3

√

√

II.3

√

√

√

√ √

√

√

√

√

√

II.2

√

II.2

2

√

√ √

√

II.1

√

√

√ √

√

Co

urs

es

60

5

10

7

20

5

30

3

40

2

70

1

20

6

30

4

40

3

70

2

90

2

Co

urs

es

60

5

10

7

20

5

30

3

40

2

70

1

20

6

30

4

40

3

70

2

90

2


F-730-01-03

19

Pro

gra

mm

e IL

Os

Kn

ow

led

ge

an

d U

nd

erst

an

din

g

II.2

1

II.3

9

√ √

II.2

0

√

II.3

8

√ √

II.1

9

√

II.3

7

II.1

8

√

√ √

I.36

I.17

√ √

II.3

5

II.1

6

II.3

4

√ √

II.1

5

II.3

3

√

√

II.1

4

√ √

II.3

2

√

√

√ √

√

II.1

3

√

II.3

1

√ √

√

II.1

2

√

√

II.3

0

√

II.1

1

√

√ √

II.2

9

√

√

II.1

0

√

√ √ √

II.2

8

√

√ √

√ √

II.9

√

II.2

7

√

√ √ √

√

II.8

√ √

II.2

6

√ √ √

II.7

√

II.2

5

√

√

√

√ √

√

II.6

√ √ √

II.2

4

√ √ √

II.5

√ √ √

II.4

√ √

√ √

II.2

3

√

II.3

√

√

√

√

√

√

√

√ √

√

II.2

√

√

II.2

2

√ √ √

√

√

II.1

√

√

Co

urs

es

20

7

30

5

40

5

70

3

80

1

90

3

11

0

11

1

30

6

30

7

30

8

Co

urs

es

20

7

30

5

40

5

70

3

80

1

90

3

11

0

11

1

30

6

30

7

30

8


F-730-01-03

20

Pro

gra

mm

e IL

Os

Kn

ow

led

ge

an

d U

nd

erst

an

din

g

II.2

1

√ √

√

II.3

9

√

II.2

0

√ √

II.3

8

√ √

√ √

II.1

9

II.3

7

√ √

II.1

8

√

I.36

√

I.17

II.3

5

√

II.1

6

√

√ √

√

√

II.3

4

√ √ √

√

√

II.1

5

√

√ √

√ √

II.3

3

II.1

4

II.3

2

√

II.1

3

√

II.3

1

√

II.1

2

√ √

√

II.3

0

√

II.1

1

II.2

9

√

II.1

0

√

II.2

8

√ √

√ √

II.9

√ √

√

√

II.2

7

√

II.8

√ √ √

√

√

II.2

6

√ √

II.7

√ √ √

√

√

√

II.2

5

√

II.6

√ √

√

II.2

4

II.5

√ √ √

II.4

√ √

√ √

II.2

3

√

II.3

√

√

√

√ √ √

√

√

II.2

√ √

√

√

II.2

2

√

II.1

√ √

√

√

Co

urs

es

80

2

11

2

40

4

80

3

90

1

90

5

11

3

11

5

20

8

40

6

90

4

Co

urs

es

80

2

11

2

40

4

80

3

90

1

90

5

11

3

11

5

20

8

40

6

90

4


F-730-01-03

21

Pro

gra

mm

e IL

Os

Kn

ow

led

ge

an

d U

nd

erst

an

din

g

II.2

1

II.3

9

√

II.2

0

II.3

8

II.1

9

√

II.3

7

√

II.1

8

I.36

√

I.17

II.3

5

√

II.1

6

II.3

4

II.1

5

II.3

3

√

II.1

4

√

√

II.3

2

II.1

3

√

√

√

II.3

1

II.1

2

√

II.3

0

√ √

II.1

1

√

II.2

9

√

II.1

0

√ √

II.2

8

√ √

II.9

√

II.2

7

√ √ √

II.8

√

II.2

6

√

II.7

II.2

5

√

√ √

II.6

√

II.2

4

√

√

II.5

√ √

√

√

II.4

√

II.2

3

II.3

√

√

√ √

√

√

II.2

II.2

2

√

√

II.1

Co

urs

es

31

2

70

5

21

0

80

4

80

5

12

1

12

2

Su

mer

tra

inin

g

ICD

L

Co

urs

es

31

2

70

5

21

0

80

4

80

5

12

1

12

2

Su

mer

tra

inin

g

ICD

L


F-730-01-03

22

Pro

gra

mm

e IL

Os

Pro

fess

ion

al

& P

ract

ical

skil

ls

III.

26

√ √

√ √ √

III.

25

√ √

√ √ √ √ √

III.

24

√ √

√

√ √ √

√ √ √ √ √

√ √

III.

23

√ √ √ √ √

III.

22

√ √ √ √ √

III.

21

√ √ √ √ √ √

III.

20

√

√ √ √ √ √ √

√ √

√

III.

19

√ √ √ √

√ √ √

√ √ √

√

√ √

√

III.

18

√

III.

17

III.

16

√ √

III.

15

√

III.

14

√ √

III.

13

III.

12

√

III.

11

√ √

√ √

√ √ √ √ √

III.

10

√ √ √ √ √ √ √

III. 9 √ √

√ √ √ √ √ √ √

III. 8 √ √ √ √ √

√ √

√

III. 7 √ √

III. 6 √

√ √ √ √

III. 5 √ √ √ √

√ √

√ √

√ √

III. 4 √ √

√ √

√ √

III. 3 √

√ √

√

√ √ √

√

√ √

√

√ √

√

√

√ √

√

III. 2 √ √

√

√ √ √

√

√

√ √

√

√

√ √

√

√

√ √

√

√

III. 1

√

√

√ √

√ √

√

√

√ √

√

√

√ √

√

√

√

√ √

√

√ √

Courses 10

1

20

1

50

1

50

3

60

1

60

2

10

2

10

5

20

2

30

2

50

2

60

3

10

3

20

3

30

1

50

4

60

4

10

6

20

4

31

1

40

1

50

5

60

5

10

7

20

5

30

3

40

2

70

1

20

6

30

4


F-730-01-03

23

Pro

gra

mm

e IL

Os

Pro

fess

ion

al

& P

ract

ical

skil

ls

III

.26

√ √ √ √ √ √

√ √ √

III

.25

√ √ √

√ √ √ √

√ √ √

√

III

.24

√ √

√ √

√ √ √

√

√ √

√

√

√ √

√

√

√

√ √

√

III

.23

√ √

√ √ √

√ √

III

.22

√ √

√

√ √

√ √ √ √ √

III

.21

√

√

√ √ √ √ √ √

III

.20

√ √

√

√ √ √

√ √ √ √

III

.19

√ √ √ √

√

√ √

III

.18

√

√

III

.17

√ √

III

.16

√ √

√

III

.15

√ √ √

III

.14

√ √ √

√

III

.13

√ √

III

.12

√

√ √ √ √ √

√ √

III

.11

√

√ √ √ √ √ √

√

III

.10

√ √ √

√

√ √

III

.9 √ √ √ √

√

III

.8 √ √ √ √

√ √

III

.7 √ √ √ √

√ √

III

.6 √

√ √

III

.5 √

√ √

√ √

III

.4 √ √

√ √

√

III

.3 √ √ √

√ √ √ √

√ √

III

.2 √

√ √

√ √ √ √

√ √

√

III

.1

√

√

√

√

√

√

√ √ √

√ √ √

√ √

√

√ √

Courses 40

3

70

2

90

2

20

7

30

5

40

5

70

3

80

1

90

3

11

0

11

1

30

6

30

7

30

8

80

2

11

2

40

4

80

3

90

1

90

5

11

3

11

5

20

8

40

6

90

4

31

2

70

5

21

0

80

4

12

1

12

2

80

5

Su

mer

train

ing

ICD

L


F-730-01-03

24

Pro

gra

mm

e IL

Os

Inte

llec

tual

skil

ls

IV.1

9

√

√ √ √

√

IV.1

8

√ √ √ √

√ √

√

√ √

IV.1

7

√

√ √ √ √

√

√

√

√

√ √

√

√

√ √

√

√ √ √ √

IV.1

6

√

√

IV.1

5

√ √ √ √

√ √

√

IV.1

4

√ √

IV.1

3

√ √ √ √ √ √ √

IV.1

2

√ √ √

IV.1

1

√ √ √ √ √

IV.1

0

IV.9

√ √

IV.8

√ √ √ √ √

√ √

√ √ √

IV.7

√

√ √

√ √ √

√ √ √

√ √ √

√ √

√ √

IV.6

√ √ √ √

IV.5

√ √

√ √

IV.4

√ √ √ √ √ √ √ √ √

IV.3

√ √ √ √ √

IV.2

√ √ √ √

IV.1

√ √ √ √

√ √

√ √

√ √

Co

urs

es

10

1

20

1

50

1

50

3

60

1

60

2

10

2

10

5

20

2

30

2

50

2

60

3

10

3

20

3

30

1

50

4

60

4

10

6

20

4

31

1

40

1

50

5

60

5

10

7

20

5

30

3

40

2

70

1

20

6

30

4


F-730-01-03

25

Pro

gra

mm

e IL

Os

Inte

llec

tual

skil

ls

IV.1

9

√ √ √ √ √

√

√

IV.1

8

√ √ √ √ √

√

√

√

√ √

√

√ √

IV.1

7

√ √ √

√ √

√ √ √ √

√ √ √

√

IV.1

6

√ √

IV.1

5

√

√ √ √

√ √ √ √ √

IV.1

4

√

√

√ √ √ √ √

IV.1

3

√

√ √ √ √ √

IV.1

2

√ √ √ √ √ √

IV.1

1

√

√ √

√

IV.1

0

√ √

IV.9

√ √ √

IV.8

√ √ √ √ √

√

IV.7

√ √ √ √

√ √

IV.6

√ √

√

√

IV.5

√ √ √ √

IV.4

√ √ √

√ √

√

√

IV.3

√

√ √

√

√

√

IV.2

√ √ √

√

IV.1

√ √ √ √

√

Co

urs

es

40

3

70

2

90

2

20

7

30

5

40

5

70

3

80

1

90

3

11

0

11

1

30

6

30

7

30

8

80

2

11

2

40

4

80

3

90

1

90

5

11

3

11

5

20

8

40

6

90

4

31

2

70

5

21

0

80

4

80

5

121

122

Su

mer

train

ing

ICD

L


F-730-01-03

26

Pro

gra

mm

e IL

Os

Gen

eral

an

d t

ran

sfer

ab

le s

kil

ls

V.1

3

√

√

√

√

√

√

√

√

√ √

√

√

√ √

√

√

√

√

√

√

√

√

√

√ √

V.1

2

√

√ √

√ √ √ √ √ √ √

√

√ √

√

√

V.1

1

√

√ √

√

√

√

√ √

√

√ √

√

√ √ √

√ √ √ √

V.1

0

√ √

V.9

√

√ √

√

√ √

√ √

√ √ √

√

√ √

√

V.8

√

√ √

√ √

√ √ √ √ √ √ √ √ √

√

√

V.7

√

√ √

√

√

√

√ √

√ √

√

√

√ √

√

√ √

√

√

V.6

√ √

√ √

√

√ √

√ √

√ √

√ √

V.5

√ √

√

√

√

√ √

√

√ √

√

√

√ √

√

√

√

√

√

√

√

√

V.4

√ √

√

√

√

√ √

√

√ √

√

√

√ √

√

√

√ √

√

√

V.3

√

√ √

√

√

√

√ √

√

√ √

√

√ √

√

√

√ √

√

√

V.2

√

√ √

√

√

√

√

√ √

√

√ √

√

√ √

√

√

√ √

√

√

V.1

√

√

√ √

√

√

√

√

√

√ √

√

√

√

√

√

√

√

√

√

√

√

√ √

√

√

Co

urs

es

10

1

20

1

50

1

50

3

60

1

60

2

10

2

10

5

20

2

30

2

50

2

60

3

10

3

20

3

30

1

50

4

60

4

10

6

20

4

31

1

40

1

50

5

60

5

10

7

20

5

30

3

40

2

70

1

20

6

30

4


F-730-01-03

27

Pro

gra

mm

e IL

Os

Gen

eral

an

d t

ran

sfer

ab

le s

kil

ls

V.1

3

√ √

√

√ √

√

√

√

√

√

√

√

√

√ √

√

√

√

√

√

√ √

√

√

√

√

√

√

√

V.1

2

√ √

√ √

√

√

√ √ √ √

√

√ √

√ √

√

√

√

V.1

1

√

√ √ √

√

√

√

√

√

√

√

√

√ √

√ √

√

√ √

√ √

√

√

√

V.1

0

√ √ √

V.9

√

√ √ √

√

√

√ √

√

√

√

√ √

√

√

√ √

√

√

√

√

√

V.8

√ √

√ √

√

√

√ √ √

√ √ √ √

√

√

√

√

√

√

√

V.7

√ √ √

√

√ √ √ √

√

√ √ √ √ √

√

√

√

V.6

√

√ √

√ √

√

√ √

√

√

√

√ √

√

√ √ √ √

V.5

√ √ √

√

√

√

√

√

√

√

√

√

√

√

√ √

√

√

√ √

√ √

√

√

V.4

√ √

√

√

√

√

√

√

√ √ √

√ √

√ √

√

√

√

√

√

√

√ √

√

V.3

√ √

√ √

√

√

√

√ √

√

√

√ √

√ √

√

√

√

√

√

√

√ √

√

√

√

V.2

√ √ √

√

√

√

√

√ √

√ √

√ √

√

√

√

√ √

√

√

√

√

√ √

V.1

√

√

√

√

√

√

√

√

√

√

√

√ √

√ √

√

√

√

√

√

√

√

√

√

√ √

√

√

Cou

rses

403

702

902

207

305

405

703

801

903

110

111

306

307

308

802

112

404

803

901

905

113

115

208

406

904

312

705

210

804

805

121

122

Su

mer

tra

inin

g

ICD

L


F-730-01-03

28

Courses contributing to the programme

a. Compulsory

- First year/ First Semester

Code

No Course Title

No of

hours/week NARS Programme ILOs

Lect. Lab.

101

History of

pharmacy +

pharmacy

orientation

2 0

1.4,1.8, 1.9, 1.10 I.9, I.10, I.17, I.18, I.19,

I.20, I.21, I.22

2.1, 2.21 II.1, II.2, II.3, II.4, II.39

3.1, 3.9 III.1, III.20

4.13 IV.18

5.1, 5.2, 5.3, 5.4,5.5,

5.6, 5.8, 5.9, 5.10

V.1, V.2, V.3, V.4, V.5, V.6,

V.7, V.8, V.9, V.11, V.12,

V.13

201 Botany and

medicinal

plants

2 1

1.3, 1.6, 1.7, 1.8, 1.10 I.6, I.8,I.13,I.14, I.16,I.17,

I.18, I.19,I.21,I.22

2.1, 2.2, 2.3, 2.4, 2.7,

2.15, 2.20,

II.3, II.5, II.7, II.8, II.16,

II.27, II.28, II.30, II.38

3.1,3.2, 3.3, 3.4, 3.5,

3.8, 3.9, 3.10, 3.12

III.1, III.3, III.5, III.9, III.10,

III.11, III.19, III.20, III.21,

III.24, III.25, III.26

4.1, 4.2, 4.3, 4.5, 4.7,

4.9, 4.13

IV. 1, IV.3, IV.4, IV.7,

IV.11, IV.13, IV.17

5.1, 5.2, 5.4, 5.5, 5.6,

5.8, 5.9, 5.10

V.1, V.2, V.3, V.7, V.8, V.9,

V.11, V.12, V.13

501 Organic

Chemistry(1) 3 1

1.1, 1.3, 1.8,1.9, 1.10 I.1, I.7, I.18, I.20, I.21, I.22

2.1, 2.4 II.1, II.8

3.1, 3.2, 3.4, III.1, III.2, III.3, III.8

4.5, 4.13 IV.7, IV.8, IV.17

5.1, 5,10 V.1, V.13

503 Mathematics 2 0

1.7, 1.8 I.15,I.18

2.1, 2.17 II.2, II.34

3.11 III.24

4.6 IV.9

5.4, 5.10 V.6,V.13

601

Physical

Chemistry+

General

Chemistry

2 1

1.1, 1.7 , 1.8 I.1,I.15,I.18

2.1,2.2, 2.3, 2.42.7,

2.16, 2.17

II.1,II.2,II.5,II.7,II.8, II.15,

II.33, II.34

3.1, 3.2, 3.4, 3.11 III.1,III.2,III.3,III.6,III.9,III.

24

4.5,4.13 IV.7,IV.17,

5.1, 5.2,5.3, 5.4, 5.5,

5.8,5.9, 5.10

V.1,V.2,V.3,V.4,V.5,V.6,V.

7,V.8,V.11,V.12,V.13

602 Analytical

Chemistry(1) 2 1

1.1, 1.3, 1.8 I.1,I.7,I.18

2.1,2.2, 2.3, 2.4 II.1,II.5,II.7,II.8

3.1, 3.2, 3.4, 3.11 III.1,III.2,III.3,III.6,

III.9,III.24

4.5 IV.7,IV.8,

5.1, 5.2, 5.3, 5.4,

5.5,5.8,5.9, 5.10

V.1,V.2,V.3,V.4,V.5,V.7,V.

8,V.11,V.12,V.13


F-730-01-03

29

- First year/ Second Semester

Code

No Course Title

No of


Lect. Lab.

102 Physical

pharmacy 2 1

1.1 , 1.3, 1.8 I.1, I.2, I.6, I.7, I.8, I.17,

I.18, I.19

2.1, 2.2, 2.6, 2.17 II.1, II.2, II.3, II.4, II.5, II.6,

II.13, II.14, II.34

3.2,3.3, 3.8, III.2, III.3, III.4, III.5, III.19

4.1,4.2, 4.4, 4.13 IV.1, IV.2, IV.3, IV.6,

IV.17, IV.18

5.1, 5.2, 5.3, 5.4, 5.6,

5.8, 5.10

V.1, V.2, V.3, V.4, V.5, V.6,

V.7, V.9, V.11, V.13

105

Accounting and

Pharmacy

business

administration

2 0

1.7, 1.8 I.14, I.15, I.16, I.17, I.18,

I.19

2.1, 2.18, 2.19, 2.20 II.4, II.35, II.36, II37, II.38

3.12 III.25, III.26

4.12, 4.14 IV.16, IV19

5.1, 5.2, 5.3, 5.4, 5.5,

5.6, 5.7, 5.8, 5.10

V.1, V.2, V.3, V.4, V.5,V.6,

V.7,V.8, V.9, V.10, V.11,

V.13

202 Pharmacognosy

(1) 2 1

1.1, 1.3,1.4, 1.6, 1.7,

1.8, 1.91.10

I.1,I.6,I.8,13,I.14,I.16,I.17,I.

18,I.19,I.21,I.22

2.1,2.2,2.3, 2.4, 2.6,

2.7, 2.11, 2.12, 2.13,

2.152.19, 2.20

II.1,II.3,II.4,II.5,II.7,II.8,II.1

3,II.15,II.16,II.23,II.24,II.25,

II.26,II.27,II.28,II.30,II.37,II

.38

3.1, 3.2, 3.3, 3.4, 3.5,

3.6, 3.8, 3.9, 3.10,

3.11, 3.12


III.10, III.11, III.12, III.14,

III.19, III.20, III.21, III.22,

III.23, III.24, III.25, III.26

4.1, 4.3, 4.4, 4.5, 4.7,

4.9, 4.11, 4.12, 4.13,

4.14

IV. 1, IV.4, IV.5,IV.6,IV.7,

IV.8, IV.11, IV.13,

IV.15,IV.16, IV.17,

IV.18,IV.19

5.1, 5.2, 5.3,5.4, 5.5,

5.6, 5.8, 5.9, 5.10

V.1, V.2, V.3,V.4,V.5,V.6,

V.7, V.8, V.9, V.11, V.12,

V.13

302 Medical

terminology 1 0

1.5,1.8, 1.10 I.11, I.12, I.17, I.22

2.12.11, 2.12 II.3, II.22, II.25

3.5 III.1, III.11

4.13 IV.17

5.1 V.1, V.2

502 Organic

chemistry(2) 2 1

1.1, 1.3,1.8, 1.9,1.10 I.1, I.7, I.18, I.20, I.21, I.22

2.1, 2.4, 2.5, II.1, II.8, II.10

3.1,3.2, 3.4 III.1, III.2, III.3, III.8

4.5, 4.13 IV.7, IV.8, IV.17

5.1, 5.10 V.1, V.13

603 Analytical

chemistry(2) 2 1

1.1, 1.3, I.1,I.6,I.7

2.1,2.3, 2.4,2.17 II.1,II.7,II.8, II.34 3.1, 3.2, 3.4 III.1,III.2,III.3,III.10 4.3, 4.5,4.13 IV.4,IV.7,IV.17 5.1, 5.2,5.3, 5.4,

5.5,5.8,5.9, 5.10 V.2,V.3,V.4,V.5,V.6,V.8,V.

11,V.12,V.13


F-730-01-03

30

- Second year/ First Semester

Code

No Course Title

No of


Lect. Lab.

103 Pharmaceutics

(1) 2 1

1.1, 1.2, 1.3, 1.8 I.1, I.2, I.3, I.4, I.5, I.6,

I.7, I.8, I.17, I.18, I.19

2.1, 2.2, 2.6, 2.17 II.1, II.2, II.3, II.4, II.5,

II.6, II.13, II.14, II.34

3.2, 3.3, 3.8 III.2, III.3, III.4, III.5,

III.19

4.1, 4.2, 4.4, 4.13 IV.1, IV.2, IV.3, IV.6,

IV.17, IV.18

5.1, 5.2, 5.3, 5.4, 5.6, 5.8,

5.10

V.1, V.2, V.3, V.4, V.5,

V.6, V.7, V.9, V.11,

V.13

203 Pharmacognosy

(2) 2 1

1.1,1.3, 1.6, 1.7, 1.8, 1.10 I.1, I.6, I.8, I.13,I.14,I.16,

I.17,I.18,I.19,I.22

2.1, 2.2,2.4, 2.12, 2.13,

2.14, 2.15, 2.16

II.3,II.5,II.8,II.26,

II.27,II.29,II.30, II.31

3.1, 3.2, 3.3, 3.4,3.5, 3.7,

3.8, 3.9, 3.10, 3.11, 3.12

III.1, III.2, III.4, III.5,

III.9, III.11,III.16,III.19,

III.20, III.21, III.23,


4.1,4.3, 4.5, 4.8, 4.9,

4.11, 4.13

IV. 1, IV.4, IV.7,IV.12,

IV.13, IV.15, IV.17,

IV.18,

5.1, 5.2,5.3, 5.4, 5.5, 5.6,

5.8, 5.9, 5.10

V.1, V.2, V.3,V.4,V.5,

V.7, V.8, V.9, V.11,

V.12, V.13

301 Anatomy,

Histology and

Physiology

3 1

1.5,1.8, 1.10 I.11, I.12, I.17, I.22

2.1, 2.5, 2.9, 2.11, 2.14 II.3, II.10, II.12, II.19,

II.22, II.24, II.29

3.1, 3.5, 3.10, 3.11 III.1, III.11, III.22, III.24

4.14 IV.19

5.1 V.1

504 Organic

Chemistry (3) 3 1

1.1 , 1.2,1.3, 1.8,1.9,

1.10

I.1, I.3, I.7, I.18, I.19,

I.20, I.21, I.22

2.1, 2.2, 2.3, 2.4, 2.7 II.1, II.5, II.7, II.8, II.9,

II.15

3.1, 3.2, 3.4, 3.8 III.1, III.2, III.3, III.7,

III.8, III.19

4.5, 4.13 IV.7, IV.8, IV.17

5.1, 5.2, 5.3, 5.10 V.1, V.4, V.5, V.13

604 Analytical

Chemistry(3) 2

1

1.3, 1.7 I.6, I.7, I.14

2.1,2.2, 2.3 II.1, II.5, II.7, II.34

3.1, 3.2, 3.4, 3.11 III.1, III.2, III.3, III.10,

III.24

4.3, 4.5, 4.13 IV.4, IV.7, IV.8, IV.17,

IV.18

5.1, 5.2, 5.3, 5.4, 5.5,5.8,

5.9, 5.10

V.1, V.2, V.3, V.4, V.5,

V.6, V.7, V.8, V.11,

V.12, V.13


F-730-01-03

31

- Second year/ Second Semester

Code

No Course Title

No of


Lect. Lab.

106 Pharmaceutics (2) 3 1

1.1, 1.2, 1.3, 1.8 I.1, I.2, I.3, I.4, I.5, I.6, I.7, I.8,

I.17, I.18, I.19

2.1, 2.6 II.1, II.2, II.3, II.4, II.13, II.14

3.2, 3.3, 3.8 III.2, III.3, III.4, III.5, III.19

4.1, 4.13 IV.1, IV.2, IV.17, IV.18

5.1, 5.2, 5.3, 5.4, 5.6,

5.8, 5.10

V.1, V.2, V.3, V.4, V.5, V.6, V.7,

V.9, V.11, V.13

204 Pharmacognosy (3) 2 1

1.1, 1.3, 1.6, 1.7, 1.8,

1.10

I.1, I.6,I.7,I.8, I.13,I.14,I.16,

I.17,I.18,I.19, I.21,I.22

2.1, 2.2, 2.4, 2.13,

2.15, 2.16

II.3, II.5, II.8,

II.27,II.28,II.30,II.31,II.32

3.1, 3.2,3.3, 3.4, 3.5,

3.7, 3.8,3.9, 3.10,

3.11, 3.12

III.1, III.2, III.4, III.5, III.9, III.11,


III.23, III.24, III.25, III.26

4.1, 4.3, 4.5, 4.8, 4.9,

4.11, 4.13

IV. 1, IV.4, IV.7, IV.12, IV.13,

IV.15, IV.17,IV.18,

5.1, 5.2,5.3, 5.4, 5.5,

5.6, 5.7, 5.8, 5.9, 5.10

V.1, V.2, V.3,V.4,V.5, V.7, V.8,

V.9, V.11, V.12, V.13

311 Psychology 1 0

1.5,1.7, 1.8, 1.9, 1.10 I.12, I.14, I.17, I.19, I.20, I.21

2.1 II.4

3.1 III.1

4.14 IV.19

5.1, 5.4, 5.7, 5.10 V.1, V.7, V.10, V.13

401 Pathology

+Parasitology 2 1

1.4,1.5, 1.6, 1.7, 1.8,

1.10

I.10, I.11,I.12,I.13, I.14,

I.17,I.18,II.21,I.22

2.2, 2.10, 2.11, 2.12,

2.14

II.3, II.20, II.22, II.25, II.26, II.29.

3.1, 3.5, 3.6, 3.9,

3.10, 3.11

III.1, III.11, III.20III.22, III.24.

4.8, 4.9, 4.13, 4.14 IV.12, IV.13, IV.19.

5.1, 5.5,5.6, 5.8, 5.10 V.1, V.8, V.9, V.11, V.13

505 Organic Chemistry

(4) 2 1

1.1 , 1.2, 1.3, 1.8,1.9,

1.10

I.1, I.3, I.7, I.18, I.19, I.20, I.21,

I.22

2.1, 2.2, 2.3, 2.4 II.1, II.5, II.7, II.8, II.9

3.1, 3.2, 3.4, 3.8 III.1, III.2,III.3, III.7, III.8, III.19

4.5, 4.13 IV.7, IV.8, IV.17

5.1, 5.2, 5.3,5.10 V.1, V.4, V.5, V.13

605 Instrumental

Analysis 2 1

1.3, 1.7 I.6, I.7, I.14

2.1, 2.2, 2.3, 2.4,

2.17 II.1, II.3, II.5, II.7, II.8, II.34

3.1, 3.2, 3.4, 3.8, 3.11 III.1, III.2, III.3, III.6, III.9, III.10,

III.24

4.3, 4.5, 4.13 IV.4, IV.7, IV.8, IV.17

5.1, 5.2, 5.3, 5.4, 5.5,

5.8, 5.9, 5.10 V.1, V.2, V.3, V.4, V.5, V.6, V.7,

V.8, V.11, V.12, V.13

-


F-730-01-03

32

- Third year/ First Semester

Code

No Course Title

No of


Lect. Lab.


1.1, 1.2, 1.3, 1.8 I.1, I.2, I.3, I.4, I.5, I.6,

I.7, I.8, I.17, I.18, I.19

2.1, 2.6, 2.10 II.1, II.2, II.3, II.4, II.13,

II.14, II.20, II.21

3.2, 3.3, 3.8, 3.11 III.2, III.3, III.4, III.5,

III.19, III.24

4.1, 4.13 IV.1, IV.2, IV.17, IV.18

5.1, 5.2, 5.3, 5.4, 5.6,

5.8, 5.9, 5.10

V.1, V.2, V.3, V.4, V.5,

V.6, V.7, V.9, V.11,

V.12, V.13

205 Phytochemistry (1) 3 1

1.1, 1.2, 1.3, 1.4, 1.5, 1.6,

1.7, 1.8, 1.9, 1.10

I.1, I.2, I.5, I.8, I.9,

I.12,I.13,I.16, I.17,I.18,

I.19, I.21,I.22

2.1, 2.2, 2.3, 2.4,2.5,

2.13, 2.15, 2.16, 2.20

II.1, II.3, II.5, II.7, II.8,

II.9, II.12, II.27, II.30,

II.31, II.38

3.2, 3.3, 3.4,3.8, 3.9



III.20

4.1, 4.2, 4.3, 4.5, 4.7,

4.11

IV.1, IV.3, IV.4, IV.5,

IV.7, IV.8, IV.11, IV.15

5.1, 5.2, 5.3, 5.4, 5.5, 5.6,

5.9, 5.10

V.1, V.2, V.3, V.4, V.5,

V.7, V.8, V.9, V.12,

V.13

303 Pharmacology (1) 2 1

1.3, 1.4, 1.5, 1.6, 1.8,

1.10

I.7, I.9, I.10, I.11, I.12,

I.13, I.17, I.18, I.19, I.20,

I.21, I.22

2.1, 2.5, 2.6, 2.8, 2.11,

2.12, 2.13, 2.14, 2.17

II.3, II.10, II.11, II.12,

II.14, 11.17, II.22, II.24,

II.25, II.27, II.28, II.29,

II.34

3.1, 3.4, 3.8,3.5, 3.9,

3.103.11, 3.12


III.20, III.21, III.22,


4.3, 4.5, 4.9, 4.10, 4.11,

4.13

IV.5, IV.7, IV.13, IV.14,

IV.15, IV.17

5.1, 5.2, 5.3, 5.4, 5.6, 5.8,

5.10

V.2, V.3, V.5, V.9, V.11,

V.13

402 Basic microbiology &

Immunology 2 1

1.3, 1.10 I.8, I. 21, I.22

2.10, 2.11 II.20, II.22, II.23, II.24,

3.1, 3.2, 3.6 III.1, III.2, III.14, III.15,

4.4, 4.6, 4.7, IV.6, IV.9, IV.11

5.3 V.5

701 Biochemistry (1) 3 1

1.1, 1.3, 1.7, I.1, I.7, I.14

2.1, 2.3, 2.11 II.1, II.3, II.7, II.23

3.1, 3.2, 3.8 III.1, III.2, III.3, III.19

4.13 IV.17

5.1, 5.2, 5.3,5.4, 5.5, 5.8,

5.9

V.1, V.2, V.3, V.4, V.5,

V.6, V.7, V.8, V.11,

V.12


F-730-01-03

33

- Third year/ Second Semester

Code

No Course Title

No of


Lect. Lab.

206 Phytochemistry (2) 2 1

1.1, 1.2,1.3, 1.4,1.5, 1.6,

1.7, 1.8, 1.10

I.1, I.2, I.5, I.8, I.9, I.12,

I.13, I.16, I.17, I.18, I.19,

I.21, I.22

2.1, 2.2, 2.3, 2.4, 2.5,2.13,

2.15, 2.16, 2.20

II.1, II.3, II.5, II.7, II.8,

II.9, II.12, II.28, II.30,

II.31, II.38

3.3, 3.4, 3.8, 3.9



III.20

4.1, 4.2,4.3, 4.5, 4.7, 4.11 IV.1, IV.3, IV.4, IV.5,

IV.7, IV.8, IV.11, IV.15

5.1, 5.2, 5.3,5.4, 5.5, 5.6,

5.8, 5.9, 5.10

V.1, V.2, V.3, V.4, V.5,

V.7, V.8, V.9, V.12,

V.13

304 Pharmacology (2) 3 1

1.3, 1.4, 1.5,1.6, 1.7,1.8,

1.9, 1.10

I.7, I.9, I.10, I.11, I.12,

I.13, I.14, I.17, I.18, I.19,

I.20, I.21, I.22

2.1, 2.4, 2.5, 2.11, 2.12,

2.13, 2.14, 2.16, 2.17, 2.20

II.3, II.8, II.10, II.11,

II.12, II.22, II.24, II.25,

II.27, II.28, II.29, II.32,

II.34, II.38

3.1,3.4, 3.5, 3.9, 3.10, 3.12 III.1, III.8, III.11, III.20,

III.21, III.22, III.23, II.25

4.9, 4.10, 4.11, 4.13 IV.13, IV.14, IV.15,

IV.17,

5.1,5.2, 5.3, 5.4, 5.5, 5.6,

5.8, 5.9

V.1, V.2, V.3, V.4, V.5,

V.7, V.8, V.9, V.11, V.12

403 Medical

Microbiology 3 1

1.4, 1.5, 1.7, 1.8, 1.10 I.9, I.10, I.11,I.12, I.14,

I.17, I.18, I.21,I.22

2.1, 2.10, 2.11, 2.12 II.3, II.20, II.22, II.24,

II.25, II.26.

3.1, 3.6, 3.9, 3.10 III.1, III.13, III.14, III.20,

III.22, III.23.

4.8 IV.12.

5.1, 5.10 V.1, V.13.

702 Biochemistry (2) 3 1

1.1, 1.3, 1.5, 1.6, 1.7, 1.8,

1.10

I.1, I.7, I.11, I.13, I.14,

I.16, I.18, I.19, I.22

2.1,2.3, 2.112.12 II.3, II.7, II.24, II.25,

II.26

3.1, 3.2, 3.8 III.1, III.2, III.3, III.19

4.13 IV.17

5.1, 5.2, 5.3, 5.4,5.5,5.6,

5.8, 5.9

V.1, V.2, V.3, V.4, V.5,

V.6, V.7, V.8, V.11,

V.12

902 Hospital Pharmacy 1 1

1.4, 1.9 I.1,I.4,I.5, I.9,I.12,I.15,

I.17,I.18,I.19,I.20,I.21

2.1, 2.8,2.9, 2.12, 2.17,

2.21 II.3,II.18,II.19,II.26,II.34

3.1, 3.2, 3.3, 3.10, 3.12 III.1, III.2, III.4, III.21,

III.26

4.10 IV.14

5.1, 5.4, 5.6, 5.8, 5.10 V.1,V.6,V.9,V.11,V.13


F-730-01-03

34

- Fourth year/ First Semester

Code

No Course Title

No of


Lect. Lab.

207 Herbal Medicine 2 0

1.1, 1.5, 1.7, 1.8, 1.10 I.2, I.9, I.10, I.12, I.16, I.17, I.18,

I.19, I.21, I.22

2.1, 2.2,2.5, 2.8, 2.12, 2.13,

2.14, 2.15, 2.16

II.3, II.4, II.5, II.10, II.11, II.12,

II.18, II.25, , II.27, II.28, II.29,

II.30, II.31, II.32

3.1,3.2, 3.5, 3.7, 3.9, 3.10,

3.11


III.20, III.21, III.22, III.23, III.24

4.1, 4.4, 4.9, 4.10, 4.11, 4.13 IV.1, IV.6, IV.13, IV.14, IV.15,

IV.17

5.1, 5.2, 5.5, 5.6, V.1, V.3, V.4, V.8, V.9, V.12,

V.13

305 Pharmacology (3)+

Drug Interaction 3 1

1.4, 1.5, 1.6, 1.7, 1.8, 1.10 I.9, I.10, I.11, I.12, I.13, I.14,

I.17, I.18, I.19, I.21, I.22

2.1, 2.5, 2.6, 2.8, 2.11, 2.12,

2.13, 2.14, 2.16, 2.20

II.3, II.10, II.11, II.12, II.14, II.17,

II.18, II.22, II.24, II.25, II.26,

II.27, II.28, II.29, II.32, II.38

3.1, 3.5, 3.6, 3.9, 3.10, 3.12 III.1, III.11, III.12, III.13, II.15,

III.20, III.21, III.22, III.23, III.25

4.9, 4.10, 4.11 IV.13, IV.14, IV.15,

5.1, 5.2, 5.3, 5.5, 5.8, 5.9,

5.10

V.1, V.2, V.3, V.4, V.5, V.8,

V.11, V.12, V.13

405 Public health 1 0

1.3, 1.4, 1.10 I.8, I.9, I.21, I.22

2.1, 2.10, 2.12, 2.16 II.3, II.20, II.25, II.32.

3.1, 3.9, 3.10 III.1, III.20, III.22

4.8, IV.12

5.1, 5.2, 5.6 V.1, V.4, V.9.

703 Clinical

biochemistry &

molecular biology

2 1

1.1, 1.3, 1.5, 1.6, 1.7, 1.8,

1.10 I.1, I.7, I.11, I.12, I.13, I.14, I.16,

I.17, I.18, I.19, I.21, I.22

2.1, 2.2, 2.3, 2.11, 2.12 II.3, II.6, II.7, II.22, II.23, II.24,

II.25, II.26

3.1, 3.2, 3.8 III.1, III.2, III.3, III.19

4.13 IV.17

5.1, 5.2, 5.3, 5.4, 5.5, 5.8,

5.9, 5.10

V.1, V.2, V.3, V.4, V.5, V.6, V.7,

V.8, V.11, V.12, IV.13

801 Pharmaceutical

chemistry (1) 2 1

1.1, 1.3, 1.4, 1.6,1.8, 1.9,

1.10, I.1, I.2, I.6, I.7, I.10, I.13, I.18,

I.19, I.20, I.21, I.22

2.1,2.2,2.4, 2.5, 2.13, 2.17 II.3, II.5, II.8, II.9, II.10, II.11,

II.28, II.34

3.2, 3.4, 3.11, 3.12 III.2, III.3, III.7, III.9, II.24, III.25

4.3, 4.5, 4.6, 4.13 IV.4, IV.8, IV.9, IV.10, IV.17,

IV.18

5.1, 5.2, 5.3, 5.4, 5.5, 5.6,

5.8, 5.9, 5.10 V.1, V.2, V.3, V.4, V.5, V.6, V.8,

V.9, V.11, V.12, V.13

903

Pharmacy practice,

Community

pharmacy,

Pharmacy

Legislations

3 1

1.4, 1.5,1.6, 1.7, 1.8, 1.9,

1.10 I.9, I.10, I.12, I.13, I.14, I.16,

I.17, I.18, I.19, I.20, I.21

2.1, 2.13, 2.21 II.3, II.27, II.28, II.39

3.1, 3.3, 3.5, 3.9, 3.10, 3.11,

3.12 III.1, III.4, III.11, III.20,III.21,

III.24, III.26

4.11, 4.14 IV.15, IV.19

5.1, 5.2, 5.3, 5.4, 5.5, 5.6,

5.8, 5.9, 5.10 V.1, V.2, V.3, V,4, V.5, V.7,

V.8,V.9, V.11, V.12, V.13


F-730-01-03

35

- Fourth year/ Second Semester

Code

No Course Title

No of


Lect. Lab.


1.8,1.10 I.17, I.18, I.19, I.21, I.22

2.1, 2.2, 2.6, 2.20 II.1, II.2, II.3, II.4, II.5,II.13,

II.14, II.38

3.2, 3.3, 3.8 III.4

4.1, 4.7 IV.1, IV.2, IV.11

5.1, 5.2, 5.3, 5.4,5.5, 5.6, 5.9,

5.10

V.1, V.2, V.3, V.4, V.5, V.6,

V.7, V.8, V.9, V.11, V.12,

V.13

111 Biopharmaceutics &

Pharmacokinetics 2 1

1.1,1.7, 1.8 I.1, I.2, I.16, I.17, I.18

2.1, 2.2, 2.8 II.1, II.2, II.3, II.4, II.6, II.17,

II.18

3.1, 3.11, 3.12 III.1, III.24, III.25

4.7, 4.10, 4.13 IV.11, IV.14, IV.17, IV.18

5.1, 5.2, 5.3, 5.4, 5.6, 5.8,

5.10

V.1, V.2, V.3, V.4, V.5, V.6,

V.7, V.9, V.11, V.13

306

Biostatistics &

Biological

Standardization of

Drugs

2 1

1.3,1.6, 1.7, 1.8, 1.9, 1.10 I.7, I.13, I.15, I.18, I.19, I.20,

I.21

2.4, 2.9, 2.11, 2.13, 2.16, 2.17 II.8, II.19, II.22, II.27, II.31,

II.34,

3.1, 3.4, 3.7, 3.11, 3.12 III.1, III.8, III.18, III.24, II.25

4.3, 4.5, 4.13 IV.5, IV.7, IV.8, IV.17

5.1, 5.3,5.4, 5.8, 5.9, 5.10 V.1, V.2, V.5, V.6, V.11,

V.12, V.13

307 Toxicology 3 1

1.1, 1.3,1.4, 1.5, 1.8, 1.9, 1.10 I.1, I.7, I.9, I.10, I.11, I.12,

I.17, I.18, I.19, I.20, I.21, I.22

2.2, 2.2, 2.5, 2.11, 2.12, 2.13,

2.16

II.3, II.4, II.6, II.10, II.22,

II.24, II.25, II.26, II.27, II.28,

II.31, II.32, II.33

3.2, 3.5, 3.7, 3.9, 3.10, 3.12


III.17, III.18, III.20, III.21,

III.22, III.26

4.8, 4.9, 4.10, 4.11 IV.12, IV.13, IV.14, IV.15

5.2, 5.3, 5.8, 5.10 V.3, V.4, V.5, V.11, V.13

308 First aid 1 0

1.4, 1.5,1.8, 1.9, 1.10 I.9, I.10, I.11, I.12, I.17, I.18,

I.19, I.20, I.21, I.22

2.1, 2.11, 2.12, 2.16, 2.21 II.3, II.22, II.25, II.32, II.33,

II.39

3.7, 3.9, 3.10 III.16, III.20, III.22,

4.11 IV.15

5.2, 5.3, 5.8, 5.10 V.3, V.5, V.11, V.13

802 Pharmaceutical

Chemistry (2) 3 1

1.1, 1.3, 1.4,1.6, 1.8, 1.9, 1.10 I.1, I.2, I.6, I.7, I.10, I.13,

I.18, I.19, I.20, I.21, I.22

2.1, 2.2, 2.3, 2.4, 2.13, 2.17 II.3, II.5, II.7, II.8, II.28, II.34

3.2, 3.4, 3.11, 3.12 III.2, III.3, III.7, III.8, III.9,

III.10, II.24, III.25

4.3, 4.5, 4.13 IV.4, IV.7, IV.8, IV.17, IV.18

5.1, 5.2, 5.3, 5.4, 5.5, 5.6,

5.8, 5.10

V.1, V.2, V.3, V.4, V.5, V.6,

V.8, V.9, V.11, V.13


F-730-01-03

36

- Fifth year/ First Semester

Code

No Course Title

No of


Lect. Lab.

112 Industrial pharmacy

(1) 2 1

1.3 I.6, I.7, I.8

2.1, 2.2, 2.7, 2.20 II.1, II.2, II.3, II.4, II.6,

II.15, II.16, II.38

3.8 III.19

4.2 IV.3

5.1, 5.2, 5.3, 5.4, 5.6, 5.8,

5.10

V.1, V.2, V.3, V.4, V.5,

V.6, V.7, V.9, V.11, V.13

404 Pharmaceutical

microbiology 2 1

1.3, 1.4, 1.8, 1.9 I.6, I.7, I.8, I.9, I.10, I.17,

I.20.

2.1, 2.3, 2.7, 2.10 II.3, II.7, II.15, II.16,

II.20, II.21.

3.2, 3.5, 3.6, 3.9, 3.10, 3.12


III.15, III.20, III.22,

III.23, III.26

4.2, 4.3, 4.8, 4.11, 4.14 IV. 3, IV. 4, IV. 5, IV.12,

IV.15, IV.19.

5.3, 5.4, 5.6 V.5, V.6, V.9.

803 Pharmaceutical

Chemistry (3) 3 1

1.1, 1.2, 1.3, 1.4, 1.6, 1.8,

1.9, 1.10

I.1, I.2, I.3, I.6, I.7, I.10,

I.13, I.18, I.19, I.20, I.21,

I.22

2.1, 2.2, 2.4, 2.13, 2.17 II.3, II.5, II.8, II.9, II.28,

II.34

3.2, 3.4, 3.11, 3.12 III.2, III.3, III.7, III.8,

III.9, III.10, II.24, III.25

4.3, 4.5, 4.13 IV.4, IV.7, IV.8, IV.17,

IV.18

5.1, 5.2, 5.3, 5.4, 5.5, 5.6,

5.8, 5.10

V.1, V.2, V.3, V.4, V.5,

V.6, V.8, V.9, V.11, V.13

901 Clinical pharmacy and

therapeutics 3 1

1.4, 1.5, 1.6, 1.7,1.8, 1.9,

1.10

I.9, I.10, I.11, I.12, I.13,

I.14, I.16, I.17, I.18, I.19,

I.20, I.21

2.5, 2.8, 2.11, 2.12, 2.13,

2.14

II.12, II.18, II.22, II.25,

II.26, II.27, II.28, II.29

3.1, 3.5, 3.10, 3.11, 3.12

III.1, III.11, III.12,

III.21,III.22, III.24,

III.26

4.9, 4.10, 4.11, 4.14 IV.13, IV.14, IV.15,

IV.19

5.1, 5.2, 5.3, 5.4, 5.5, 5.6,

5.8, 5.9, 5.10

V.1,V.2,V.3,V.4,V.5

V.6,V.7,V.8,V.9,V.11,

V.12, V.13

905 Marketing 1 0

1.7, 1.8, 1.9, 1.10 I.14, I.17, I.18, I.19, I.20,

I.21

2.1, 2.18, 2.19 II.4, II.35, II.36, II.37

3.11 III.24

4.12 IV.16

5.1, 5.7, 5.10 V.1, V.10, V.13


F-730-01-03

37

- Fifth year/ Second Semester

Code

No Course Title

No of


Lect. Lab.

113 Industrial

Pharmacy(2) 3 1

1.3 I.6, I.7, I.8

2.1, 2.3, 2.7 II.1, II.2, II.3, II.4, II.7, II.15,

II.16

3.8 III.19

4.2 IV.3

5.1, 5.2, 5.3, 5.4, 5.6, 5.8,

5.10

V.1, V.2, V.3, V.4, V.5, V.6,

V.7, V.9, V.11, V.13

115 Quality Control &

Quality assurance 3 1

1.1, 1.3, , 1.8, I.1, I.2, I.6, I.7, I.8, I.17, I.18,

I.19

2.1, 2.3, 2.4, 2.7, 2.17,

2.20

II.1, II.2, II.7, II.8, II.9, II.15,

II.16, II.34, II.38.

3.1, 3.2, 3.3, 3.4, 3.8,3.11,

3.12


III.10, III.19, III.24, III.25,

III.26

4.2, 4.3, 4.13 IV.3, IV.4, IV.5, IV.17, IV.18

5.1, 5.2, 5.3, 5.4, 5.5, 5.6,

5.8, 5.9, 5.10

V.1, V.2, V.3, V.4, V.5,V.6, V.7,

V.8,V.9, V.11, V.12, V.13

208 Quality control &

Natural Products 3 1

1.1, 1.2, 1.3, 1.4, 1.5, 1.6,

1.7, 1.8, 1.9, 1.10

I.1, I.2, I.3,I.6, I.7, I.8, I.9,

I.10, I.12, I.13, I.16, I.17, I.18,

I.19, I.20, I.21, I.22

2.1, 2.2, 2.3, 2.4, 2.5, 2.6,

2.7, 2.10, 2.11, 2.12, 2.13,

2.15, 2.16, 2.17, 2.19, 2.20

, 2.22

II.1, II.2, II.3, II.4, II.5, II.6,

II.7, II.8, II.9, II.10, II.12,

II.13, II.16, II.20, II.21, II.23,

II.26, II.28, II.30, II.31, II.32,

II.34, II.37, II.38, II.39

3.1, 3.2, 3.3, 3.4, 3.6, 3.7,

3.8, 3.9, 3.11, 3.12

III.1, III.2,III.3, III.5, III.6,


III.15, III.17, III.19, III.20,


4.1, 4.2, 4.3,4.4, 4.5,4.7,

4.8, 4.11, 4.13, 4.14

IV.1, IV.3, IV.4, IV.6, IV.7,

IV.8, IV.11, IV.12, IV.15,

IV.17, IV.18, IV.19

5.1, 5.2, 5.3, 5.4, 5.5, 5.6,

5.8, 5.9, 5.10

V.1, V.2, V.3, V.4, V.5, V.6,

V.7, V.8, V.9, V.11, V.12,

V.13

406 Biotechnology 2 0

1.2, 1.3,1.6, 1.7, 1.8, 1.10 I.3, I.6, I.13, I.16, I.17, I.21,

I.22.

2.1, 2.2, 2.3, 2.4, 2.5, 2.7,

2.10, 2.17

II.3, II.6, II.7,II.8, II.9, II.12,

II.15, II.21, II.34.

3.4, 3.6, 3.11 III.6, III.7, III.8, III.10, III.14,

III.24.

4.1, 4.2, 4.3, 4.5, 4.6, 4.7,

4.13

IV.2, IV. 3, IV. 4, IV. 5, IV.7,

IV.8, IV.9, IV.11, IV.18

5.1, 5.2, 5.3, 5.6, 5.9, 5.10 V.1, V.2, V.3, V.4, V.5, V.9,

V.12, V.13.

904 Drug Information 1 0

1.5, 1.7, 1.9, 1.10 I.12, I.16, I.17, I.18, I.19, I.20,

I.21

2.20 II.3, II.38

3.10, 3.11, 3.12 III.23, III.24, III.26

4.12, 4.13 IV.16, IV.17, IV.18,

5.1, 5.2, 5.4, 5.5, 5.7, 5.9 V.1, V.2, V.3, V.4, V.6, V.7,

V.8, V.10, V.12


F-730-01-03

38

b. Elective Courses:

Code

No Course Title

No of


Lect. Lab.

210 Marine Drugs 2 0

1.6, 1.8, 1.10 I.13, I.17, I.18, I.21, I.22

2.1, 2.2, 2.4, 2.13 II.3, II.4, II.5, II.8, II.27,

II.28,

3.1, 3.4, 3.11, 3.12 III.1, III.6, III.10, III.24,

III.25, III.26.

4.5, 4.9, 4.13, 4.14 IV.7 , IV.13, IV.18, IV.19

5.1, 5.2, 5.3, 5.5, 5.6, 5.8, 5.9,

5.10

V.1, V.2, V.3, V.4, V.5, V.8,

V.9, V.11, V.12, IV.13

312 Clinical

Pharmacology 1 0

1.4, 1.5, 1.6, 1.8, 1.10, I.9, I.10, I.11, I.12, I.13, I.17,

I.18, I.19, I.21, I.22

2.1,2.5, 2.11, 2.12, 2.13, 2.14 II.3, II.10, II.11, II.12, II.22,

II.24, II.25, II.26, II.27, II.28,

II.29

3.1, 3.5, 3.10 III.1, III.11, III.12, III.21,

III.22, III.23

4.9, 4.10, 4.11, 4.13, 4.14 IV.13, IV.14, IV.15, IV.18,

IV.19

5.1, 5.2, 5.10 V.1, V.3, V.4, V.13

705 Clinical nutrition 2 0

1.5,1.6, 1.7, 1.8, 1.10 I.11, I.12, I.13, I.14, I.16,

I.17, I.18, I.19, I.21, I.22

2.1, 2.11, 2.12, 2.15 II.3, II.22, II.24, II.25, II.30

3.1, 3.5 III.1, III.11, III.12

4.4 IV.19

5.1, 5.2, 5.3, 5.4, 5.5, 5.8, 5.9,

5.10, 5.18 V.1, V.2, V.3, V.4, V.5, V.6,

V.7, V.8, V.11, V.12, V.13

804 Drug Design 2 0

1.6, 1.8, 1.9, 1.10 I.13, I.18, I.19, I.20, I.22

2.5 II.10

3.11 III.24

4.6, 4.13 IV.9, IV.10, IV.18

5.1,5.4, 5.5, 5.6, 5.10 V.2, V.7, V.8, V.9, V.13

805 Drug Synthesis 2 0

1.6, 1.8, 1.9,1.10 I.13, I.18, I.19, I.20, I.22

2.2, 2.4 II.5, II.9

3.2, 3.4, 3.11 III.3, III.7, III.8, III.24

4.13 IV.18

5.1, 5.5, 5.6, 5.10 V.2, V.8, V.9, V.13

121

Novel dosage

forms

2 0

1.1, 1.2, 1.3, 1.4, 1.6, 1.8, 1.10 I.2, I.4, I.5, I.6, I.8, I.9, I.13,

I.17, I.18, I.19, I.21, I.22

2.1, 2.2, 2.6 II.3, II.5, II.13, II.14

3.3, 3.6 III.4, III.5,III.24, III.25

4.1, 4.4, 4.13 IV.1, IV.2, IV.6, IV.18

5.1, 5.2, 5.3, 5.5, 5.6, 5.8, 5.9, 5.10 V.1,V.2,V.3, V.4, V.5, V.7,

V.8, V.9,V.11, V.12, V.13

122

Cosmetic

products

2 0

1.1, 1.2, 1.3, 1.5, 1.8, 1.10 I.2, I.4, I.5, I.6, I.11, I.17,

I.18, I.19, I.21, I.22

2.1, 2.2, 2.6, 2.12 II.3, II.5, II.13, II.14,II.25

3.2, 3.3, 3.11, 3.12 III.4, III.5,III.24, III.25

4.1, 4.4, 4.13 IV.1, IV.2, IV.6, IV.18

5.1, 5.2, 5.3,5.4, 5.5, 5.6, 5.8, 5.9,

5.10

V.1,V.2,V.3, V.4, V.5, V.7,

V.8, V.9,V.11, V.12, V.13


F-730-01-03

39

Summer Training:

Summer Training NARS Programme ILOs

(graduation

requirement)

(300 hour) :

- During summer

vacation preceding the

3rd

, 4th

or5th

year of

study

- 1.1, 1.2, 1.3, 1.4, 1.5, 1.7, 1.8,

1.9, 1.10

- I.2, I.5, I.6, I.8, I.9, I.10, I.12, I.14,

I.17, I.18, I.19, I.20, I.21, I.22

- 2.1, 2.2, 2.6, 2.9, 2.13, 2.15,

2.16, 2.18, 2.19, 2.21

- II.3, II.5, II.6, II.13, II19, II.27, II.30,

II.33, II.36, II.37, II.39

- 3.1, 3.3, 3.5, 3.8, 3.9, 3.10,

3.11

- III.1, III.5, III.12, III.19, III.20, III.21,


- 4.8 - IV.12

- 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7,

5.8, 5.9, 5.10

- V.1, V.3, V.5, V.7, V.8, V.9, V.10,

V.11, V.12, V.13

ICDL:

NARS Programme ILOs

ICDL

(graduation

requirement)

- 1.7, 1.8, 1.10 - I.15, I.16, I.18, I.22

- 2.19 - II.35

- 3.11 - III.24

- 4.13 - IV.18

- 5.1, 5.2,5.4, 5.5, 5.8, 5.9 - V.2,V.3, V.6, V.7, V.8, V.11, V.12

The following matrix shows fulfilment of the programme ILOs by the different courses

contributing to the programme as well as the summer training and ICDL as graduation

requirement

4- Curriculum structure and contents

4a – Programme duration: five years

4b – Programme structure:

Year Semester Lectures

hours/ week

Laboratory /

Practical/week

Total

hours

1st 1

st 13 4 17

2nd

11 4 15

2nd

1st 12 5 17

2nd

12 5 17

3rd

1st 12 5 17

2nd

12 5 17

4th

1st 13 4 17

2nd

13 4 17

5th

1st 13 4 17

2nd

14 3 17


F-730-01-03

40

Comparison between curriculum structures of the programme vs. NARS

Summer Training: (graduation requirement) (300 hour) :

- During summer vacation preceding the 3rd

, 4th

or 5th

year of study

ICDL: as a graduation requirement

c-Compulsory

Code

No Course Title Units

No of

hours/week Academic

Year Semester

Lect. Lab.

101 History of pharmacy +

pharmacy orientation 2 2 0 First First

201 Botany and medicinal

plants 3

2 1 First First

501 Organic Chemistry(1) 4 3 1 first

first

503 Mathematics 2 2 0 First First

601 Physical Chemistry+

General Chemistry 3 2 1 First First

602 Analytical Chemistry(1) 3 2 1 First

First

102 Physical pharmacy 3 2 1 First Second

105

Accounting and

Pharmacy business

administration

2 2 0 First Second

202 Pharmacognosy (1) 3 2 1 First Second

302 Medical terminology 1 1 0 First

Second

502 Organic chemistry(2) 3 2 1 First Second

603 Analytical chemistry(2) 3 2 1 First Second

103 Pharmaceutics (1) 3 2 1 Second First

Reference

value(NARS)

Percentage

(%)

Number

of hours Sciences

( 4-2%) 1.8% 3 Pharmacy

management

(40-35%) 45.5% 76.5 Pharmaceutical

(25-20%) 20.2% 34 Medical

(10-15%) 7.7% 13 Pharmacy practice

(10-15%) 17.3% 28 Basic

(5-10 %) 4.5% 7.5 Health and

environmental

(2-4 %) 1.2 % 2 Behavioural and

social

(UP to 8%) 2.38% 4 Discretionary


F-730-01-03

41

Code


No of

hours/week Academic

Year Semester

Lect. Lab.

203 Pharmacognosy (2) 3 2 1 Second First

301 Anatomy, Histology and

Physiology 4 3 1 Second First

504 Organic Chemistry (3) 4 3 1 Second First

604 Analytical Chemistry(3) 3 2 1 Second First

106 Pharmaceutics (2) 4 3 1 Second Second

204 Pharmacognosy (3) 3 2 1 Second Second

311 Psychology 1 1 0 Second Second

401 Pathology +Parasitology 3 2 1 Second Second

505 Organic Chemistry (4) 3 2 1 Second Second

605 Instrumental Analysis 3 2 1 Second Second

107 Pharmaceutics (3) 3 2 1 Third First

205 Phytochemistry (1) 4 3 1 Third First

303 Pharmacology (1) 2 2 1 Third First

402 Basic microbiology &

Immunology 3 2 1 Third First

701 Biochemistry (1) 4 3 1 Third First

206 Phytochemistry (2) 3 2 1 Third Second

304 Pharmacology (2) 4 3 1 Third Second

403 Medical Microbiology 4 3 1 Third Second

702 Biochemistry (2) 4 3 1 Third Second

902 Hospital Pharmacy 2 1 1 Third Second

207 Herbal Medicine 2 2 0 Fourth First

305 Pharmacology (3)+ Drug

Interaction 4 3 1 Fourth First

405 Public health 1 1 0 Fourth First

703 Clinical biochemistry &

molecular biology 3 2 1 Fourth First

801 Pharmaceutical

chemistry (1) 3 2 1 Fourth First

903

Pharmacy practice,

Community pharmacy,

Pharmacy Legislations

4 3 1 Fourth First

110 Pharmaceutics (4) 2 2 0 Fourth Second

111 Biopharmaceutics &

Pharmacokinetics 3 2 1 Fourth Second

306 Biostatistics & Biological

Standardization of Drugs 3 2 1 Fourth Second

307 Toxicology 4 3 1 Fourth Second

308 First aid 1 1 0 Fourth Second

802 Pharmaceutical 4 3 1 Fourth Second


F-730-01-03

42

Code


No of

hours/week Academic

Year Semester

Lect. Lab.

Chemistry (2)

112 Industrial pharmacy (1) 3 2 1 Fifth First

404 Pharmaceutical

microbiology 3 2 1 Fifth First

803 Pharmaceutical

Chemistry (3) 4 3 1 Fifth First

901 Clinical pharmacy and

therapeutics 4 3 1 Fifth First

905 Marketing 1 1 0 Fifth First

113 Industrial Pharmacy(2) 4 3 1 Fifth Second

115 Quality Control &

Quality assurance 4 3 1 Fifth Second

208 Quality control &

Natural Products 4 3 1 Fifth Second

406 Biotechnology 2 2 0 Fifth Second

904 Drug Information 1 1 0 Fifth Second

d-Elective courses

Code


No.

hours/week Academic

year Lecture

705 Clinical nutrition 2 2

Fifth

804 Drug design 2 2 Fifth

805 Drug synthesis 2 2 Fifth

906 Advanced clinical pharmacy 2 2 Fifth

907 Clinical pharmacy practice 2 2 Fifth

908 Advanced clinical

pharmacokinetics 2 2 Fifth

909 Communication skills for

pharmacist 2 2 Fifth

910 Clinical pharmacoeconomics 2 2 Fifth


F-730-01-03

43

5- Programme admission requirements

General secondary school certificate with major in biology and chemistry, or an equivalent

certificate from a foreign institute recognized by the university.

6- Regulations for progression and programme completion

"Students who pass all subjects will be transferred from one academic year to the next.

However, the student may still be transferred if he/she has failed in not more than four

subjects with a maximum of two basic subjects from the same academic year or from

previous years of study. In such cases, students "carrying" subjects from one year to the

next should re-sit for their "failed" subjects in their proper respective semesters. Final year

students who have failed in a maximum of two basic subjects and two complementary ones

in that year or from previous years can re-sit for their exams in those subjects in September

of the same year. Should the student fail again, he/she has to re-sit for his/her exams in

those subjects in their proper respective semesters thereafter as many times as necessary

until he/she succeeds."

Bylaws and Regulations for Undergraduate Students, Faculty of Pharmacy, Cairo

University Article (10).

Enrolment opportunities for "regular" and "external" students:

Educational

Year

Enrolment opportunities for students

As Regular student As External students

First Two opportunities None

Second Two opportunities One opportunity

Third Two opportunities Three opportunities

Fourth Two opportunities Three opportunities

Fifth Two opportunities

Two opportunities, but if the student succeeds

in half the number of subjects, he/she would be

allowed to re-sit for the exam in the subjects

he/she has failed indefinitely until he/she is

graduated.

“Once a student exhausts the number of opportunities of being a "regular" student, he becomes

an "external" student for a certain number of times according to the above table. Once an

"external" student in a certain year succeeds in his/her exams for that year to allow him/her to

be transferred to the following year, he/she automatically becomes registered as a "regular"

student in the next level."

Bylaws and Regulations for Undergraduate Students, Faculty of Pharmacy, Cairo University

Article (11a).


F-730-01-03

44

7- Methods and Regulation for programme applicants 'assessment

Method of assessment Intended learning outcomes(ILOs)

1 Written examination Knowledge and understanding

Intellectual

2 Practical examination

Knowledge and understanding

Intellectual

Professional and practical

3 Oral examination

Knowledge and understanding

Intellectual

General and transferable

4 Others (posters, field visit,

presentation, projects …….etc.

Intellectual

General and transferable

Programme Evaluation :

The Evaluator Tool Samples

1 Senior students Questionnaire, brain storming 10-15 %

2 Alumni Questionnaire 500 / year

3 Stakeholders Questionnaire 50 / year

4 External evaluator for

programme and courses

Site visit, document

examination 100 %

5i Internal audit Site visit, document

examination 100 %

5ii Internal evaluators for courses Document examination 90 %

Programme coordinator:

Name: Prof. Dr. Seham A. Elkheshen

Signature: ………………………………………………………………………………………………………………………………………………………..

Date: /

programme specifications bachelor of pharmaceutical sciences · programme specifications bachelor...

Documents